Experiences and perspectives of Marketing Authorisation Holders towards the monitoring of medication safety in pregnancy

ENTIS affiliate member Dr Michael Ceulemans and colleagues from the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven, Belgium, have published their informative results from a qualitative study investigating the experiences and perspectives of pharmacovigilance specialists at Marketing Authorisation Holders (pharmaceutical companies) towards the safety monitoring of medication exposures in pregnancy. More information can be found here.

Photo by Antenna on Unsplash